Navigation Links
Cornell Nutritional Expert, Vermont Baby Formula Company Urge Parents Not to Dilute Formula with Extra Water
Date:12/3/2008

href="http://www.pbmproducts.com" target="_new">http://www.pbmproducts.com.

About PBM

PBM is privately owned and based in Gordonsville, VA. PBM companies specialize in manufacturing, distributing, and marketing consumer food, nutritional, and pharmaceutical products. PBM companies include PBM Holdings, Inc., PBM Products, LLC, PBM Nutritionals, LLC, PBM Canada Holdings, Inc., PBM (Guangzhou) Nutritionals Co., Ltd., and PBM Products Mexico, S. de R.L. de C.V. For more information, visit http://www.pbmproducts.com.


    Contact:  Joe Shields
              Director of Public Relations
              (800) 959-2066 ext. 1131
              jshields@pbmproducts.com

'/>"/>
SOURCE PBM Nutritionals, LLC
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration
2. Healthy restaurants help make us fat, says a new Cornell study
3. The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell
4. White House awards Weill Cornells Bruce McCandliss highest honor for early career scientists
5. Weill Cornell receives $2.4 million in grants from Gates Foundation to fight tuberculosis
6. NewYork-Presbyterian/Weill Cornell creates world-class cancer center
7. By color-coding atoms, new Cornell electron microscope promises big advance in materials analysis
8. $50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center
9. Weill Cornell team identifies potential new drug targets against hormone-dependent breast cancer
10. Weill Cornell receives funding to study creation of new elder abuse center
11. Weill Cornell Medical College Announces First Commencement of Its New Medical School Graduates in Doha, Qatar, May 8, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round 2Within3 Expands into Mobile Applications 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Pennsylvania Schools Report Decrease in Bullying Behaviors 61526 1Pennsylvania Schools Report Decrease in Bullying Behaviors 61526 2Smoking Causes Blindness 61525 1Smoking Causes Blindness 61525 2Lampooning of U S Healthcare is Just What the Doctors Ordered as RoboDoc Begins its DVD Rounds on November 24th 21 61523 1Lampooning of U S Healthcare is Just What the Doctors Ordered as RoboDoc Begins its DVD Rounds on November 24th 21 61523 2